Michele Corry
Senior Editor at Cataract & Refractive Surgery Today
Editor-in-Chief for @CRSToday. Follow us on Instagram @CRSToday.
Articles
-
2 months ago |
crstodayeurope.com | Eric D. Donnenfeld |Michele Corry |David Calkins
Dry eye disease (DED) continues to frustrate surgeons and patients alike with its multifactorial nature and resistance to one-size-fits-all solutions. Although current therapies offer varying degrees of relief, a growing pipeline of investigational treatments is targeting the root causes of ocular surface disease. From addressing meibomian gland dysfunction (MGD) to advancing care for neurotrophic keratopathy (NK), these therapies could reshape the management of complex cases.
-
Jan 14, 2025 |
crstoday.com | Eric D. Donnenfeld |Michele Corry |David Calkins
We noticed you’re blocking ads Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated. In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page. Need help? Click here for instructions.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 176
- Tweets
- 113
- DMs Open
- No
RT @CRSToday: We're excited to reveal the winners of our 2023 CRST photo competition! Explore the extraordinary visuals our colleagues have…
RT @CRSToday: 🚨 Final Hours! 🚨 Last chance to participate in our annual photo contest. If you haven’t submitted your photos, now is the tim…
RT @CRSToday: 🏆 The top entries in each category will earn a spot in our November/December 2023 issue. Additionally, one Grand Prize Winner…